July 8, 2009 : Xconomy: Kineta Acquires Multiple Sclerosis, Diabetes Drug Candidates to Test Unusual Biotech Strategy

July 7, 2009 : Kineta Acquires Novel Drug Candidates from Airmid for Potential Treatment of Multiple Sclerosis, Type 1 Diabetes and other Autoimmune Diseases

February 2, 2007 : Protein Angst

December 12, 2005: Natural Compounds Block Autoimmune Response in Diabetes, Arthritis

November 21, 2001:  Sea Anemone Toxin Halts Experimental Multiple Sclerosis; Findings May Lead To New Treatments for Disease

December 7, 2001: Sea Anemone May Provide Drug to Treat Multiple Sclerosis